Literature DB >> 11994384

Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium.

O Gubbay1, H O D Critchley, J M Bowen, A King, H N Jabbour.   

Abstract

Functional PRL receptors are expressed in the human endometrium during the secretory phase of the menstrual cycle in which PRL stimulates tyrosine phosphorylation of Janus kinase 2 and STAT (signal transducer and activator of transcription) 1 and 5. In this study, we investigated the effect of PRL on the MAPK/ERK pathway in the human endometrium. Human endometrial tissue was collected during the mid to late secretory phase of the menstrual cycle. Western blot analysis performed on proteins, extracted after up to 30 min culture with PRL, demonstrated rapid tyrosine and threonine phosphorylation of ERK 1 and 2 MAPKs. The phosphorylation of ERK, in response to PRL, was localized by immunohistochemistry to glandular epithelial cells and a subset of stromal cells. Using immunofluorescence histochemistry, PRL-induced phosphorylation of ERK in the stromal compartment was localized to the uterine-specific CD56(+) natural killer (NK) cells. We have demonstrated that the PRL receptor is expressed in uterine CD56(+) NK cells in situ by immunofluorescence and in purified decidual CD56(+) NK cells by RT-PCR and Western blotting analysis. We have further demonstrated phosphorylation of ERK 1 and 2 in cultures of purified uterine CD56(+) NK cells, in response to PRL. Our data demonstrate that PRL stimulates the ERK pathway in multiple cellular compartments of the human endometrium and identify uterine CD56(+) NK cells as novel PRL target cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994384     DOI: 10.1210/jcem.87.5.8515

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Immunoregulation of fetal and anti-paternal immune responses.

Authors:  Matthew M Seavey; Tim R Mosmann
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Regulation of facilitative glucose transporters and AKT/MAPK/PRKAA signaling via estradiol and progesterone in the mouse uterine epithelium.

Authors:  Sung Tae Kim; Kelle H Moley
Journal:  Biol Reprod       Date:  2009-02-04       Impact factor: 4.285

Review 3.  Evolution of non-cytotoxic uterine natural killer cells.

Authors:  Satyan Kalkunte; Clinton O Chichester; Francesca Gotsch; Charles L Sentman; Roberto Romero; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2008-05       Impact factor: 3.886

Review 4.  Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium.

Authors:  M Králícková; P Síma; Z Rokyta
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

5.  Transformation of a transposon into a derived prolactin promoter with function during human pregnancy.

Authors:  Deena Emera; Günter P Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

6.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 7.  Killer Timing: The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health.

Authors:  Rupsha Fraser; Ana Claudia Zenclussen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

8.  Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.

Authors:  Naveen K Neradugomma; Dharmalingam Subramaniam; Ossama W Tawfik; Vincent Goffin; T Rajendra Kumar; Roy A Jensen; Shrikant Anant
Journal:  Carcinogenesis       Date:  2013-11-21       Impact factor: 4.944

9.  Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.

Authors:  Prasad Dandawate; Gaurav Kaushik; Chandrayee Ghosh; David Standing; Afreen Asif Ali Sayed; Sonali Choudhury; Dharmalingam Subramaniam; Ann Manzardo; Tuhina Banerjee; Santimukul Santra; Prabhu Ramamoorthy; Merlin Butler; Subhash B Padhye; Joaquina Baranda; Anup Kasi; Weijing Sun; Ossama Tawfik; Domenico Coppola; Mokenge Malafa; Shahid Umar; Michael J Soares; Subhrajit Saha; Scott J Weir; Animesh Dhar; Roy A Jensen; Sufi Mary Thomas; Shrikant Anant
Journal:  Gastroenterology       Date:  2019-11-29       Impact factor: 22.682

10.  Prolactin activates mitogen-activated protein kinase signaling and corticotropin releasing hormone transcription in rat hypothalamic neurons.

Authors:  Annegret Blume; Luz Torner; Ying Liu; Sivan Subburaju; Greti Aguilera; Inga D Neumann
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.